Dx. Wang et al., Effect of lidocaine on improving cerebral protection provided by retrograde cerebral perfusion: A neuropathologic study, J CARDIOTHO, 13(2), 1999, pp. 176-180
Objective: To determine whether lidocaine can improve the neuropathologic r
esults in canine brains after retrograde cerebral perfusion (RCP).
Design: Randomized, blinded, experimental study.
Setting: University animal laboratory.
Participants: Mongrel dogs.
Interventions: Fourteen mongrel dogs were placed on 120 minutes of hypother
mic (20 degrees C) RCP. Following the RPC, they then resumed cardiopulmonar
y bypass and rewarming for 60 minutes. In the lidocaine group (n = 8), lido
caine was administered continuously; in the control group (n = 6), normal s
aline was administered. Cerebral perfusion fixation was performed at the en
d of the experiment.
Measurements and Main Results: The number of ischemic cells in 200 neurons
was counted in the parietal cortex, CA1 sector of the hippocampus, CA3 sect
or of the hippocampus, ventral posterolateral nucleus of the thalamus, and
Purkinje cells of the cerebellar cortex. Those in the parietal cortex, CA1
sector of the hippocampus, and ventral posterolateral nucleus of the thalam
us were significantly less in the lidocaine group than in the control group
(25.8 +/- 17.3 v 53.7 +/- 12.0; p < 0.01; 17.0 +/- 8.5 v 54.7 +/- 22.1; p
< 0.01; and 16.9 +/- 17.8 v 49.7 +/- 28.4; p < 0.05, respectively). The tot
al number of ischemic cells in the five examined regions was also significa
ntly less in the lidocaine group than in the control group (89.5 +/- 19.4 v
219.5 +/- 45.5; p < 0.01).
Conclusion: Continuous lidocaine significantly alleviated the ischemic neur
opathologic injury after RCP and thus possibly improved cerebral protection
. Copyright (C) 1999 by W.B. Saunders Company.